Related Experiment Video
Updated: Feb 17, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
Cost of hepatic decompensation and liver transplantation events in primary biliary cholangitis: a retrospective
Robert G Gish1, Joanna P MacEwan2, Yutong Liu2
1Robert G. Gish Consultants, LLC, San Diego, CA 92037, USA.
Insights
Primary biliary cholangitis (PBC) complications, including hepatic decompensation and liver transplantation, impose a significant economic burden. Effective patient management is crucial to reduce these high healthcare costs.
Area of Science:
- Hepatology
- Health Economics
- Clinical Research
Background:
- Primary biliary cholangitis (PBC) is associated with severe complications.
- Hepatic decompensation and liver transplantation represent major clinical events in PBC progression.
- The economic impact of these complications on healthcare systems and patients is substantial.
Purpose of the Study:
- To evaluate the economic burden of primary biliary cholangitis (PBC)-related hepatic decompensation and liver transplantation.
- To analyze costs associated with PBC disease progression using a large administrative claims database.
- To identify the financial impact of complications requiring hospitalization and transplantation.
Main Methods:
- Retrospective observational study utilizing Optum's Clinformatics® Data Mart Database.
- Inclusion of patients aged ≥18 years with a primary biliary cholangitis (PBC) diagnosis.
- Two cohorts were established: hepatic decompensation events and liver transplantation, analyzing associated costs.
Main Results:
- The mean cost per hepatic decompensation event was $63,612.09, increasing to $116,424.25 with 30-day readmission.
- The mean total cost for liver transplantation per patient was $328,336.60.
- Hospitalization for liver transplantation represented the highest per-patient cost at $226,908.70.
Conclusions:
- Primary biliary cholangitis (PBC) disease progression incurs a significant financial burden.
- Hepatic decompensation and liver transplantation are high-cost events in PBC management.
- Optimizing patient care strategies may alleviate the economic impact of advanced PBC.
Abstract:
Aim: Complications of primary biliary cholangitis (PBC) are proposed to confer substantial economic burden to patients and healthcare systems. This retrospective observational study evaluated the cost of PBC-related hepatic decompensation and liver transplantation using a large administrative claims database. Materials & methods: Patients aged ≥18 years at the time of first claim with a diagnosis of PBC were identified using Optum's de-identified Clinformatics® Data Mart Database. Two cohorts were established based on the type of event (hepatic decompensation or liver transplantation) that patients experienced on or after the date of their first claim with the PBC diagnosis. Costs for the hepatic decompensation hospitalization and 30-day post-discharge period were examined at the event level. Hospitalizations occurring within the 30-day post-discharge period after a hepatic decompensation event were considered readmissions, and costs from the initial event were combined with those from the ensuing readmissions. In the liver transplantation cohort, costs for the pretransplant evaluation, hospitalization for transplantation, and post-transplant care and complications were assessed per patient. Results: A total of 2118 and 163 patients met study inclusion criteria in the hepatic decompensation and liver transplantation cohorts, respectively. The overall mean cost per hepatic decompensation event (n = 3581) was $63,612.09. The mean cost per event with readmission within 30 days (n = 991, 27.7%) was $116,424.25; for events without readmission, the mean cost was $43,404.81. The mean total cost of liver transplantation per patient was $328,336.60. The mean cost per patient was highest for the hospitalization for transplantation ($226,908.70). Conclusion: This comprehensive cost analysis demonstrates the high-cost burden of PBC disease progression. Appropriate patient management may help to mitigate the economic burden of PBC-related hepatic decompensation and liver transplantation.
More Related Videos
07:48Intraoperative Video Consultation Following Bile Duct Transection Facilitates Direct OR Transfer for Robotic Hepaticojejunostomy at Tertiary Center
Published on: January 9, 2026
12:27Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
Published on: May 7, 2015
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow